Next-Generation Sequencing (NGS) Market Size, Share and Industry Analysis By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Regional Forecast, 2019 - 2026
Market Segmentation:
To get information on various segments, share your queries with us
SEGMENTATION
|
Segmentation |
Details |
|
By Type |
· Products · Instruments & Software · Consumables · Services |
|
By Application |
· Diagnostics · Research · Others |
|
By End User |
· Research Institutes · Healthcare Facilities & Diagnostic Centers · Pharmaceutical & Biotechnological Companies · Contract Research Organization (CROs) |
|
By Geography |
· North America (the USA and Canada) · Europe (UK, Germany, France, Italy, Spain, and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific) · Latin America (Brazil, Mexico, and Rest of Latin America) · Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa) |
NEXT-GENERATION SEQUENCING (NGS) MARKET PLAYERS
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Hoffmann-La Roche Ltd
- Agilent Technologies, Inc.
- QIAGEN
- BGI
- PerkinElmer Inc.
- Eurofins Scientific
- Macrogen, Inc.
- PierianDx
- Other prominent players
- Jul, 2019
- 2018
- 2015-2017
- 145
Healthcare Clients
Related Reports
